clenbuterol has been researched along with Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome in 2 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rett syndrome is a severe childhood onset neurodevelopmental disorder caused by mutations in methyl-CpG-binding protein 2 (MECP2), with known disturbances in catecholamine synthesis." | 1.40 | β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome. ( Crawford, B; Garcia, RI; Haggarty, SJ; Mellios, N; Sharma, J; Sheridan, SD; Sur, M; Woodson, J, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mellios, N | 1 |
| Woodson, J | 1 |
| Garcia, RI | 1 |
| Crawford, B | 1 |
| Sharma, J | 1 |
| Sheridan, SD | 1 |
| Haggarty, SJ | 1 |
| Sur, M | 1 |
| Bray, N | 1 |
2 other studies available for clenbuterol and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome
| Article | Year |
|---|---|
β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome.
Topics: Adrenergic beta-Antagonists; Animals; Behavior, Animal; Clenbuterol; Disease Models, Animal; Female; | 2014 |
Neurodevelopmental disorders: righting Rett syndrome with IGF1.
Topics: Adrenergic beta-Antagonists; Animals; Clenbuterol; Disease Models, Animal; Female; Humans; Insulin-L | 2014 |